Seelos Pharmaceuticals

Seelos Therapeutics Summary Financials Technology Signals & News About Seelos Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics. New York, New York, United States 1-10 Post-IPO Equity Public seelostherapeutics.com/ 25,497 Highlights Stock Symbol NASDAQ:SEEL Total Funding Amount $31.3M Recent News & Activity Funding Round • Jan 26, 2021 Seelos Therapeutics raised $31,250,000 / Post Ipo Equity Discover more funding rounds News • Sep 4, 2020 Benzinga — Why Seelos Therapeutics' Stock Is Trading Lower Today News • Jun 4, 2020 Yahoo Finance — Hedge Funds Warming Up To Seelos Therapeutics, Inc. (SEEL) VIEW ALL Details Industries Biotechnology Pharmaceutical Headquarters Regions Greater New York Area, East Coast, Northeastern US Founded Date Jan 1, 2016 Operating Status Active Last Funding Type Post-IPO Equity Also Known As Seelos Stock Symbol NASDAQ:SEEL Company Type For Profit Contact Email info@seelostx.com Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and other rare disorders. The Company's robust portfolio includes several late-stage clinical assetstargeting psychiatric and movement disorders, including orphan diseases.